Cullinan Associates’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $561K | Sell |
8,026
-5,000
| -38% | -$349K | 0.04% | 164 |
|
|
2025
Q1 | $957K | Hold |
13,026
| – | – | 0.07% | 128 |
|
|
2024
Q4 | $853K | Hold |
13,026
| – | – | 0.05% | 139 |
|
|
2024
Q3 | $1.01M | Hold |
13,026
| – | – | 0.06% | 138 |
|
|
2024
Q2 | $1.02M | Hold |
13,026
| – | – | 0.06% | 142 |
|
|
2024
Q1 | $883K | Buy |
13,026
+1,498
| +13% | +$101K | 0.05% | 159 |
|
|
2023
Q4 | $776K | Sell |
11,528
-2
| -0% | -$135 | 0.04% | 163 |
|
|
2023
Q3 | $781K | Sell |
11,530
-1
| -0% | -$68 | 0.05% | 155 |
|
|
2023
Q2 | $825K | Buy |
11,531
+359
| +3% | +$25.7K | 0.05% | 170 |
|
|
2023
Q1 | $775K | Sell |
11,172
-36
| -0.3% | -$2.5K | 0.05% | 170 |
|
|
2022
Q4 | $760K | Buy |
11,208
+6,126
| +121% | +$415K | 0.04% | 177 |
|
|
2022
Q3 | $279K | Sell |
5,082
-30,581
| -86% | -$1.68M | 0.02% | 210 |
|
|
2022
Q2 | $2.36M | Sell |
35,663
-879
| -2% | -$58.1K | 0.14% | 115 |
|
|
2022
Q1 | $2.42M | Sell |
36,542
-1,017
| -3% | -$67.5K | 0.13% | 117 |
|
|
2021
Q4 | $2.19M | Sell |
37,559
-2,134
| -5% | -$124K | 0.11% | 120 |
|
|
2021
Q3 | $2.38M | Buy |
+39,693
| New | +$2.38M | 0.13% | 115 |
|